Understanding High Blood Pressure
Hypertension is when the blood pressure in your body stays too much. It’s most often referred to as a “silent” disease, in that few of those with it actually feel any noticeably bad symptoms while also being chronic uncontrolled hypertension can lead to higher odds for cardiovascular problems such as heart failure from vascular damage rather than overt signs or anything.
High blood pressure is more than just a number in the monitor. You are well associated with vascular inflammation, endothelial dysfunction because of oxidative stress due to smooth muscle cell activation causing arterial stiffness and imbalance in metabolism leading to microcirculation issues. Hence, some patients become interested in supportive regenerative approaches such as stem cell therapy & DFPP.
Stem cells are thought to have a therapeutic role in both restoring vascular health.
Stem cell therapy for high blood pressure must be neither labelled as a remedy towards hypertension or substituted with medicine. Good blood pressure control still requires appropriate medical care, lifestyle management, monitoring and treatment by a qualified physician!
Mesenchymal stem cells, particularly umbilical cord (UC)-derived MSCs, are frequently examined in regenerative medicine for potential signaling properties. Active in the inflammatory, immune, vasculature and tissue microenvironments where they primarily release their bioactive molecules.
Only promote an immediate lowering of blood pressure; stem cell therapy is particular for hypertension in this case! Rather, the idea is augmenting support to environment in which their vascular system lives:
Inflammation balance
Endothelial support
Cellular communication
Microcirculation support
Tissue repair-related signaling
Oxidative stress balance
Figure 1: Stem Cell Therapy, High Blood Pressure, and DFPP for Vascular Health Support
What Is DFPP?
What is DFPP Double Filtration Plasmapheresis is a medical blood purification process that allows filtering selected elements from the plasma part of hemodialysis tubes. It has a two-layer filtration process, separating plasma from blood cells before sending larger fraction components of the separated plasma for further filtering, after which it returns the osmosis-cleaned blood to your body.
How DFPP may Help the Patient with Vascular Burden
Use of DFPP may, in selected patients, reduce burdens from circulating plasma capable of causing inflammation and lipid-related stress as well as immune stimulation or poor blood flow. These could be immune complexes, dysproteinemias (eng. abnormal plasma proteins), inflammatory‐related components and specific lipoproteins.
DFPP should not be referred to as a hypertension-specific treatment for patients with high blood pressure. Rather than using lipoprotein apheresis in its own right, it might be thought of as an adjunctive therapy applied only to very carefully selected patients where inflammation or lipid burden (or metabolic stress) or some problem with the nutrito-entis — microcirculatory milieu may offer more clues about the most fundamental aspects of health.
When is the Combination of Stem Cell Therapy and DFPP Most Effective?
The underlying reason of stem cell therapy and high blood pressure combined with DFPP can be interpreted as preparation body. As such, DFPP could relieve some of the circulating burdens and stem cell therapy is likely to regulate cellular signaling through which a balance between endothelial cells (ECs) and perivascular microenvironment.
This can be simply explained to patients as:
DFPP may facilitate internal environment readiness, while stem cell therapy mobilizes regenerative cellular signaling in the peripheral compartments.
But to medically guide and individualise this combination. Should not be a substitute for antihypertensive drugs, cardiology care or kidney evaluation / cholesterol control/ exercise /diet? weight management?.
Conclusion
Please consider stem cell therapy and the combined DFPP for high blood pressure to be parameters of “supportive regenerative medicine” rather than being a cure for hypertension. DFPP may act by addressing selected plasma burdens of inflammation, immunity and lipids while the therapy with stem cells could contribute to an improved signaling between glial-vascular axis in CNS.
This may potentially maintain microcirculation, vascular health and endothelial balance while controlling inflammation in select patients. The best-case plan would be to administer good medical screening alongside cardiac risk assessment, truthful expectation management and continuation of normal HT care.
References
World Health Organization. Hypertension Fact Sheet.
Mayo Clinic. High Blood Pressure: Symptoms and Causes.
American Heart Association. Understanding Blood Pressure Readings.
Review articles on mesenchymal stem cell paracrine signaling and vascular repair.
Review articles on Double Filtration Plasmapheresis and selective plasma filtration mechanisms.